Related Experiment Videos

Determinants of risk factor target attainment after myocardial infarction: the Perfect-CR study

Halldora Ögmundsdottir Michelsen1,2, Peter Henriksson3, John Wallert4

  • 1Department of Geriatric Medicine, Landspitali University Hospital, 105 Reykjavik, Iceland.

Insights

Cardiac rehabilitation programs with strong organizational support, including psychosocial care and nurse protocols, improve risk factor control after myocardial infarction (MI). Patient participation in exercise also enhances outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Healthcare Management

Background:

  • Cardiac rehabilitation (CR) is crucial for post-myocardial infarction (MI) recovery.
  • Understanding which CR components predict risk factor target attainment is vital for optimizing patient outcomes.
  • Predictive strength of organizational versus patient factors needs clarification.

Purpose of the Study:

  • To identify organizational and patient-level predictors of risk factor target attainment 1-year post-MI.
  • To assess the relative predictive power of CR program components versus patient characteristics.

Main Methods:

  • Surveyed organizational structure and processes of 78 Swedish CR centers.
  • Merged CR data with patient registry data (n=6755).
  • Used orthogonal partial least squares discriminant analysis to identify predictors (VIP > 0.8) of LDL-C, BP targets, and smoking abstinence.

Main Results:

  • Organizational predictors for LDL-C/BP targets: psychosocial management, nurse protocols, nurse continuity, extended hours, facilities, medical director.
  • Patient predictors for LDL-C/BP targets: low baseline LDL-C, no hypertension history, exercise-based CR participation.
  • Organizational predictors for smoking abstinence: psychosocial management, medical director, NRT/varenicline prescribing, team spirit.
  • Patient predictors for smoking abstinence: exercise-based CR, group education.

Conclusions:

  • Multiple CR organizational factors significantly predict attainment of key risk factor targets post-MI.
  • Findings can inform the design of more effective, comprehensive CR programs.
  • Optimizing CR program structure enhances patient risk factor management.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...